本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Navidea生物制药

0.0005
0.0000
成交量:1,075.00
成交额:0.54
市值:5.00万
市盈率:-0.02
高:0.0005
开:0.0005
低:0.0005
收:0.0005
52周最高:0.1300
52周最低:0.0001
股本:9,999.44万
流通股本:6,407.24万
量比:0.48
换手率:0.00%
股息:- -
股息率:- -
每股收益(TTM):-0.0260
每股收益(LYR):-0.5571
净资产收益率:-1100.12%
总资产收益率:-107.05%
市净率:-0.02
市盈率(LYR):0.00

数据加载中...

2024/02/05

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/01/27

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/01/27

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/01/27

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/01/27

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/01/27

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/01/26

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/01/26

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/01/26

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/01/26

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/01/26

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/01/17

交易所摘牌声明

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2023/12/26

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/12/21

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/12/02

重要事件披露

Form 8-K - Current report
2023/11/17

重要事件披露

Form 8-K - Current report
2023/11/15

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/10/24

交易所摘牌声明

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2023/09/07

SEC问询函

Form CORRESP - Correspondence
2023/08/11

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]